- (a) The maximum reasonable price at which amygdalin (laetrile) may be sold to a pharmacist or direct to a physician licensed in the state of Kansas shall be based on cost of production for the product plus 25% (twenty-five percent). A cost of production analysis report which has been approved by a certified public accountant shall be submitted to the secretary of health and environment prior to establishment of the wholesale cost of the product.
- (b) No increase over and above the wholesale or retail cost of amygdalin (laetrile) may be made by a physician who administers or prescribes this product. The physician may charge a fee only for his professional services in prescribing or administering amygdalin (laetrile).
(Authorized by K.S.A. 1978 Supp. 65-6b06 and 65-6b07; effective May 1, 1979.)